EuroIntervention · 2015 · 21 citations · 13 references
MedicineCardiologySurgeryCardiothoracic SurgeryClinical Decision SupportInterventional CardiologyAortic StenosisCardiac Risk AssessmentCardiac Valve SurgerySurgical Valve ReplacementTranscatheter Aortic Valve ReplacementTranscatheter Valve TherapyCardiac Outcome AssessmentCox RegressionHeart Team Decision-makingLeft Ventricular Ejection Fraction DeclineSurvival RatesSymptomatic Severe Aortic StenosisTreatment Decision-making SupportVentricular Ejection Fraction Assessment
AIMS: Little is known about how "Heart Team" treatment decisions among patients suitable for either surgical aortic valve replacement (AVR) or transcatheter aortic valve implantation (TAVI) are made under routine conditions. METHODS AND RESULTS: The "Heart Team" decision-making process was analysed with respect to124 patients of a non-randomised prospective clinical trial that included patients aged ≥75 years: 41 patients underwent AVR and 83 underwent TAVI. By use of the non-parametric classification and regression tree (CART) methodology, 21 baseline parameters were tested to reconstruct the decision process retrospectively. Next, multivariate logistic and Cox regression models were fitted to evaluate the decision and outcome relevance (two-year survival) of the parameters as identified in the CART procedure. For patients with a baseline EuroSCORE I ≥13.48%, no further cut-off points were identified and the majority of these patients underwent TAVI. Among patients with a baseline EuroSCORE I <13.48%, age and left ventricular ejection fraction (LVEF) were identified as further relevant decision parameters. The decision relevance of EuroSCORE I (p=0.003), age (p=0.024) and LVEF (p=0.047) were confirmed by multivariate analysis; however, outcome relevance can be confirmed for EuroSCORE I (p=0.015) only, while treatment decision (TAVI or AVR) was not a significant predictor of mortality (p=0.655). CONCLUSIONS: Despite or even because of the systematic risk selection according to EuroSCORE I values, we observed two-year survival rates of about 75% regardless of whether the patient received TAVI or AVR, suggesting that the decisions made by the "Heart Team" were appropriate.
13
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian, Ottavio Alfieri, Felicita Andreotti et al. · European Heart Journal · 2012 · 3.6K citations · Full text
Medicine, Cardiology, Surgery +14
Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis
Alain Cribier, Hélène Eltchaninoff, Assaf Bash et al. · Circulation · 2002 · 3.2K citations · Full text
Medicine, Cardiology, Surgery +16
Transcatheter Aortic-Valve Replacement for Inoperable Severe Aortic Stenosis
Raj Makkar, Gregory P. Fontana, Hasan Jilaihawi et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text
Medicine, Cardiology, Surgery +14